○ Area Yonsei Biomedical Science and Technology Initiative (YBSTI)

Slides:



Advertisements
Similar presentations
Combating diseases with small molecule compounds
Advertisements

Presentation to Educational Policy Committee Department of Biology Revised March, 2013 Biology Department: Position Requests.
Course Advice for B. Science and B. Biomedicine students GENETICS MAJOR.
UNC – NCRC January 2008 NC State Campus Steven Leath The University of North Carolina General Administration.
6/3/2015KNOWLEDGE INITIATIVE1 NJ Access to Science, Technology, Medicine and Business Databases New Jersey State Library New Jersey Library Network New.
Jeffery Loo NLM Associate Fellow ’03 – ’05 chemicalinformaticsforlibraries.
Occur when a societal condition is improved due to a participant’s action taken in the previous column. For example, specific contributions to: - Increased.
NICLS: Development of Biomedical Computing and Information Technology Infrastructure Presented by Simon Sherman August 15, 2005.
Medical Technology Department, Faculty of Science, Islamic University-Gaza MB M ICRO B IOLOGY Dr. Abdelraouf A. Elmanama Ph. D Microbiology 2008 Chapter.
Bioinformatics in the Biology Curriculum Gloria Rendon NCSA July 2008.
National Institute on Aging Richard J. Hodes, M.D. Director,NIA/NIH/DHHS ADC Meeting – NIH Roadmap and Budget October 2003.
The NIH Roadmap for Medical Research
The South African Malaria Initiative A Case Study E Jane Morris Bridging the Gap in Global Health Innovation - from Needs to.
SCHOOL OF BIOTECHNOLOGY National Institute of Technology Calicut Calicut , Kerala, INDIA.
Science, research and developmentEuropean Commission Chile-EC S&T Agreement Brussels, 24 September 2002 Life Sciences, Genomics and Biotechnology for Health.
121 Intramural Biomedical Projects in Rare Diseases (PIBER) Support Platforms for Research into Rare Diseases (PITER) Management Office Scientific Director.
AP Biology Ch. 20 Biotechnology.
Faculty of Medical Sciences School of Biomedical Sciences Dr Edwin Williams Director of Studies
Marine Drug Development and Delivery Prof. Dr. Basavaraj K. Nanjwade M. Pharm., Ph. D Department of Pharmaceutics KLE University College of Pharmacy BELGAUM ,
ESMD Education Presentation to Space Grant Directors March 2007 Jerry Hartman Exploration Systems Mission Directorate Education Lead.
April, The Governor's Information Technology Initiative Presentation for the Appropriations Committee, Louisiana House of Representatives.
A symposium presented by the IUPS Ethics Committee 37 th Congress IUPS Birmingham UK July 2013.
Institute for Nano·Bio Molecular Assemblies. ○ Vision And Objectives One of the Best Chemistry Department in Korea Global Top Level Chemistry Department.
Vision and Aims Chalmers AoAs should use our scientific excellences to meet the global grand challenges where we can make a difference The AoAs aims to.
○ Vision Take off to top 10 qualitative research institute Academic Excellence International Leadership in Physics Imaginative Minds.
Biotechnology and Genetic Engineering. Human Cloning-The Science In The News.
Overview Industry Overview Impacted Industries Science Business Issues Examples Where do you fit? Getting Involved Websites Other Resources.
8 October 2009Microbial Research Commons1 Toward a biomedical research commons: A view from NLM-NIH Jerry Sheehan Assistant Director for Policy Development.
Marine Biotechnology Introduction Sadia Tahir.  The most recent definition considers marine (or blue) biotechnology as "exploration of the capabilities.
12 th KOREAN PEPTIDE-PROTEIN SOCIETY SYMPOSIUM Nov. 21, 2008 Kookmin University Organizing Committee Korean Peptide-Protein Society Department of Bio and.
Consortium for Interdisciplinary Studies on Science for Aging.
Committee Meeting, June 9, 2008 Strategic Institutional Research Plan.
Pathogenomics How this project began: Ann Rose - take advantage of DNA sequence information - genomics Julian Davies - use the information to understand.
Histone Methyltransferases: Global Industry Report for Research Tools, Diagnostics and Drug Discovery
Overview of Bioinformatics Module Denis Manley.. Contact Details Lecturer Name: Denis Manley Room number: KE-1-013a
Introduction to Biotechnology Chapter 13. What is biotechnology? “ Any technique that uses living organisms or their products to make or modify a product,
Robert H. Wiltrout Director, CCR Director’s Address.
Queensland University of Technology CRICOS No J HOW RESEARCHERS FIND INFORMATION IN THE NEW DIGITAL AGE Gaynor Austen Director, Library Services.
Research Team of Elucidating Pathophysiology & Discovering Targets in Metabolic Disorders.
Why Write A Grant? Elaine M. Hylek, MD, MPH Professor of Medicine Associate Director, Education and Training Division BU CTSI Section of General Internal.
Scientific Research Landscape NCP Activity Overview
An Introduction to NCBI & BLAST National Center for Biotechnology Information Richard Johnston Pasadena City College.
Functional Vision Endpoints: OCTGT Perspective Samuel B. Barone, M.D. Office of Cellular, Tissue, and Gene Therapies Center for Biologics Evaluation and.
Published Date : 3 August 2015 World Specialty Enzymes Market.
What is Biotechnology? How Long have humans used Biotechnology?
SYNTENY LIFE SCIENCES BIOTECHNOLOGY TRAINING PROGRAM.
Concepts of Engineering and Technology BIOTECHNOLOGY Science, Technology, and Ethics Copyright © Texas Education Agency, All rights reserved.
Publishers of Quality Research
Nanotechnology in Korea
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Business Development Manager
Marine Biotechnology Introduction
Introduction and Definitions
AN ATTEMPT TO REVERSE CANCER DRUG RESISTANCE
ATOM Accelerating Therapeutics for Opportunities in Medicine
Darts Sciences Darts Target Identification.
Liposome product Liposome product in Creative Biostructure.
Antimicrobial Resistance: Plans for Korea and Beyond
Non For Profit Model for Rare Disease Therapy Development
Challenges in Biomedical Technology
Transgenic Animals Introduction.
Health Services Research Postdoctoral Fellowship
Publishers of Quality Research
MOLECULAR MECHANISMS OF AGING AND DRUG RESISTANCE
FP6 Priority 1, Life Sciences Genomics and Biotechnology for Health
Consortium: National networks in 16 European countries.
Biotechnology Training & Researching in University of Natural Science
Role of CELLULAR metabolıSM ın dısease
ประกาศกระทรวงอุตสาหกรรม ฉบับที่ 5292 (พ.ศ. 2562)
Drug Delivery.
Presentation transcript:

○ Area Yonsei Biomedical Science and Technology Initiative (YBSTI)

● Education of interdisciplinary system and establishment of research foundation as specificity of biomedical science and biotechnology. ● Pursuit of the best international competitiveness by development of the cutting edge research program of biomedical science and biotechnology. ● Reinforcement of industrial competitiveness. ● Establishment of the higher educational institutions.  Training of high quality research human resource  Construction of biomedical science and biotechnology research infrastructure & network  Selection of bioactive drug candidates, proteins and genes  Industrial application  Patent & publication  World-leading research and education initiative in biomedical science & biotechnology ○ Vision And Objectives 1st stage 2nd stage Final goal

YBSTI Director Operating Committee Advisory AdvisoryCommittee Committee EducationalInternationalCommitteeResearch Industrial Educational CommitteeEquipmentResourceCommittee ○ Organization and Participants

Function of aging gene research Genetic therapy research Cancer metastasis research Proteome research Protein network research YBSTI ○ Research Fields Life science and Biotechnology research Biotechnology industrialization Eighty faculty members of Yonsei University with specialties on biomedical science and biotechnology participate the research programs shown above.

○ Activities and Outputs ● Biotechnology Industrialization 1. Collection, preservation and distribution of the resources about microorganisms and their genetic information 2. Development of quick diagnostic techniques for microorganisms 3. Development of food safety assessment system ● Function of Aging Gene Research 1. Management of aging process 2. Fundamental understanding about aging on molecular level with searching of aging gene and finding out its function ● Development of Genetic Therapy Research 1. Development of genetic therapeutics for inveterate diseases which include development of industrialization genetic drug delivery system and guarantee new compounds ● Cancer Metastasis Research 1.Search for genes related on cancer infiltration and metastasis 2.Developement of new therapeutic target using proved function of the gene ● Proteome Research 1.The best proteome analysis's development of foundational technique & offer of service for internal and external researchers ● Protein Network Research 1. Investigation of Protein Network of cell growth‘s relation 2. Investigation of Protein Network of apoptosis's relation ● Corefacility for Biomedical S&E 1. High content screening (HCS) system 2. cDNA and small molecules library 3. International symposiums and workshops ● Life Science and Biotechnology 1. Revitalization of educational system's research of biotechnology field 2. The host organization of the introduction of a new technique 3. Improvement of research power though revitalization of basic research

○ Contact Point Prof. Chul Soo Shin Director, Yonsei Biomedical Science and Technology Initiative 202 Advanced Science & Technology Institute Bldg., Yonsei University 134 Shinchon-dong, Seoul, Korea, Tel: , Fax: